Medicinal chemistry
- Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions (23 Sep 2024)
- Regulation and marketing of cannabidiol-containing products in European countries. Pharmacists’ knowledge in Bulgaria (16 Sep 2024)
- Pharmacology and drug interactions of cannabinoids (16 Sep 2024)
- Epidiolex (Cannabidiol) Primer: Frequently Asked Questions for Patients and Caregivers (16 Sep 2024)
- Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs (02 Sep 2024)
- Drug–Cannabinoid Interactions in Selected Therapeutics for Symptoms Associated with Epilepsy, Autism Spectrum Disorder, Cancer, Multiple Sclerosis, and Pain (02 Sep 2024)
- Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM (02 Sep 2024)
- CANNabinoid Drug Interaction Review (CANN-DIR™) (28 Aug 2024)
- A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid (20 Aug 2024)
- Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis (24 May 2024)
- 1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists (27 Aug 2022)
- α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa (13 Aug 2022)
- A Phase I Trial to Determine the Pharmacokinetics, Psychotropic Effects, and Safety Profile of a Novel Nanoparticle-Based Cannabinoid Spray for Oromucosal Delivery (07 Aug 2022)
- Pharmacokinetics of Cannabidiol Following Intranasal, Intrarectal, and Oral Administration in Healthy Dogs (31 Jul 2022)
- Exploring cannabinoid bioavailability in the medical cannabis industry (25 Jul 2022)
- Cannabinoids and COVID-19 (25 Jul 2022)
- Single Compound vs. Whole Plant CBD (20 Jul 2022)
- How to use CBD & Cannabis (20 Jul 2022)
- Top CBN (Cannabinol) Questions Answered by CBD Science (18 Jul 2022)
- Cannabis-Derived Lignanamides: Potential Candidates for the Treatment of Multidrug-Resistant Cancers (18 Jul 2022)